The tracheostomy market size is projected to reach US$ 1,263.65 million by 2031 from US$ 782.91 million in 2023. The market is expected to register a CAGR of 6.2% during 2023–2031. Technological advancements in tracheostomy devices and procedures are likely to act as a future trend in the market.
Enhanced utilization of tracheostomy products in emergency medical services (EMS) further proves the product’s importance in helping healthcare professionals treat critical conditions. This is because the application of rapid airway management protocols enhances the training requirement of EMS providers for performing the procedure where appropriate, particularly during heavy trauma or when conventional intubation fails. As a result, EMS is increasingly utilizing tracheostomy products, thereby encouraging better patient outcomes during critical situations.
Many patients are now seeking sustained ventilation support; this is because chronic respiratory conditions or neuromuscular disorders have forcefully made them reach out for long-term support in their homes. A few of the latest tracheostomy products, such as portable ventilators or humidification systems, have been created specifically for home use—appearing more accessible and easier to manage. These factors contribute to a growing trend toward using tracheostomy products in home healthcare settings, enhancing patient independence and improving overall quality of patient’s life.
Advanced stages in conditions such as lung cancer, asthma, and chronic obstructive pulmonary disease (COPD) often require tracheostomy procedures for ventilation support. In addition, severe cases of infectious diseases such as tuberculosis, pneumonia, and influenza lead to respiratory failure, thereby increasing the need for tracheostomy. Critically ill patients suffering from COVID-19 infection require ventilation supported by tracheostomy. As per the World Cancer Research Fund International, in 2023, lung cancer became the most common type of cancer worldwide. In 2022, there were 2,480,675 new cases of lung cancer.
1
China
1060,584
733,291
2
US
226,033
127,653
3
Japan
136,723
83,243
4
India
81,748
75,031
5
Russian Federation
70,362
51,887
6
Germany
62,025
47,731
7
UK
50,700
35 394
8
France (Metropolitan)
49,613
36,876
9
Brazil
44,213
38,292
10
Italy
43,808
35,668
Source: World Cancer Research Fund International, WHO.
As per the American Lung Association, in 2022, ~11.7 million people, or 4.6% of adults, reported a diagnosis of chronic obstructive pulmonary disease (COPD), including chronic bronchitis or emphysema. In addition, as per the World Health Organization (WHO), in 2022, approximately 10.6 million (5.8 million men, 3.5 million women, and 1.3 million children) patients were suffering from tuberculosis. Thus, the increasing prevalence of respiratory diseases creates a burden on healthcare systems, thereby bolstering the demand for tracheostomy treatments.
A few government initiatives are focused on improving accessibility and promoting innovation in the field of tracheostomy. For instance, the Global Tracheostomy Collaborative (GTC) is a quality improvement collaborative that offers the best tracheostomy care across the globe and helps staff, managers, patients, and their families rapidly implement the best practices into healthcare settings. This collaboration aims to work together to enhance the care, safety, and quality of life of patients undergoing tracheostomy. The 8th International Symposium by GTC will be conducted in November 2024 and will focus on delivering safe, effective tracheostomy care on a global scale, achieved through data-driven innovations of interprofessional teams of physicians, nurses, respiratory therapists, speech therapists, patients, and families.
Further, Global Tracheostomy Tube Awareness Week was conducted from May 15–21, 2022, by the Tracheostomy Education Institution. The campaign aimed at increasing awareness about individuals with tracheostomy among their families and caregivers across the globe. In addition, the Joint Faculty of Intensive Care Medicine of Ireland conducted National Critical Care Tracheostomy Day on January 17, 2024, which aimed to provide education on multidisciplinary care, best practices, and insights from experts in the field of tracheostomy.
Thus, the increasing number of initiatives and awareness programs associated with tracheostomy is likely to create lucrative opportunities for the tracheostomy market growth during the forecast period.
Key segments that contributed to the derivation of the tracheostomy market analysis are type, technique, and end user.
The geographic scope of the tracheostomy market report is mainly divided into five regions: North America, Asia Pacific, Europe, South & Central America, and the Middle East & Africa. In terms of revenue, North America dominated the market in 2023. The US is the largest and fastest-growing market for tracheostomy. A tracheostomy is a medical surgery in which the airway is directly accessed by creating a hole in the front of the neck into the trachea. It is frequently carried out in situations involving airway obstruction, respiratory failure, trauma, or extended mechanical ventilation. An article in Critical Care Medicine 2020 states that ~100,000 tracheostomies are performed in the US each year. Government activities aimed at addressing the product shortage are expected to generate growth opportunities for the market in the near future. The US Food and Drug Administration (FDA) informed patients, caregivers, and healthcare providers in October 2022 that there was a shortage of tracheostomy tubes, particularly ICU Medical's Bivona tracheostomy tubes. Pediatric patients were more likely to be affected by a Bivona tracheostomy tube scarcity since there were not as many substitute tubes available with comparable functioning.
The regional trends and factors influencing the Tracheostomy Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Tracheostomy Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 782.91 Million |
| Market Size by 2031 | US$ 1,263.65 Million |
| Global CAGR (2023 - 2031) | 6.2% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Tracheostomy Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Tracheostomy Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The tracheostomy market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A key development in the tracheostomy market is listed below:
The "Tracheostomy Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
The List of Companies - Tracheostomy Market
The market is expected to register a CAGR of 6.2% during 2023–2031.
The tracheostomy market value is expected to reach US$ 1,263.65 million by 2031.
Technological advancements in tracheostomy devices and procedures are expected to emerge as a prime trend in the market in the coming years.
Medtronic Plc, ICU Medical Inc, Coloplast Corp, Fisher & Paykel Healthcare Corp Ltd, Teleflex Inc, Cook Medical Holdings LLC, Troge Medical GmbH, Fuji Systems Corp, Andreas Fahl Medizintechnik-Vertrieb GmbH, Medis Medical (Tianjin) Company Ltd, Boston Medical Products, Well Lead Medical Co. Ltd., Intersurgical Ltd, KAPITEX Healthcare Ltd, VBM Medizintechnik GmbH, SunMed Group Holdings LLC, AdvaCare Pharma USA LLC, and Angiplast Private Limited are among the key players operating in the market.
The increasing prevalence of respiratory diseases and the growing geriatric population are among the most significant factors fueling the market growth.
North America dominated the market in 2023.